Fortitude Family Office »

Allogene Therapeutics shares owned by Fortitude Family Office

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Fortitude Family Office from 13F filings

Historical chart of Fortitude Family Office investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Fortitude Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Fortitude Family Office

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.4k 1.0k 1.37
2025-06-30 $844 747 1.13

More positions owned by Fortitude Family Office

Ishares Core S&p 500 Etf Etf (IVV)
Vanguard 0-3 Month Treasury Bill Etf Etf (VBIL)
Ishares Core Msci International Developed Markets Etf Etf (IDEV)
Apple Stock (AAPL)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Knight-swift Transn Hldgs Inc Cl A Stock (KNX)
Imgp Dbi Managed Futures Strategy Etf Etf (DBMF)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Mid-cap Etf Etf (VO)
Avantis U.s. Large Cap Value Etf Etf (AVLV)
Dimensional Emerging Markets Core Equity 2 Etf Etf (DFEM)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Invesco Senior Loan Etf Etf (BKLN)
Ishares Core S&p Mid-cap Etf Etf (IJH)

View all positions for Fortitude Family Office

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Woodline Partners
Frazier Life Sciences Management
Geode Capital Management
Millennium Management
Two Sigma Investments
Patient Square Capital
Wildcat Capital Management
Renaissance Technologies
Two Sigma Advisers

View all funds holding Allogene Therapeutics